2017
DOI: 10.1097/aln.0000000000001633
|View full text |Cite
|
Sign up to set email alerts
|

To Stop or Not, That Is the Question

Abstract: Perioperative pain management suggestions for patients taking buprenorphine and presenting for elective and urgent/emergent surgery have been developed and are described here.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
56
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 113 publications
(56 citation statements)
references
References 47 publications
0
56
0
Order By: Relevance
“…The clinical evidence for managing surgical patients on therapeutic buprenorphine-naloxone regimen is based on anecdotal experience from case reports/series and institutional experience with no randomized studies and no long-term outcome results. 2,6 Despite the limited evidence, protocols for the management of these patients have recently been published. 2,6,7 Consensus in the management of patients in advance of procedures with expected moderate to severe postoperative pain is to hold buprenorphine-naloxone 72 hrs prior to surgery.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The clinical evidence for managing surgical patients on therapeutic buprenorphine-naloxone regimen is based on anecdotal experience from case reports/series and institutional experience with no randomized studies and no long-term outcome results. 2,6 Despite the limited evidence, protocols for the management of these patients have recently been published. 2,6,7 Consensus in the management of patients in advance of procedures with expected moderate to severe postoperative pain is to hold buprenorphine-naloxone 72 hrs prior to surgery.…”
Section: Discussionmentioning
confidence: 99%
“…2,6 Despite the limited evidence, protocols for the management of these patients have recently been published. 2,6,7 Consensus in the management of patients in advance of procedures with expected moderate to severe postoperative pain is to hold buprenorphine-naloxone 72 hrs prior to surgery. 8,9 However, this option was not optimal in our patient.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, due to its unique pharmacodynamics properties, it presents a unique challenge to anesthesiologists trying to treat acute pain in the perioperative setting [4,5]. Although there is no consensus regarding optimal perioperative management of patients taking these medications, most strategies include a multimodal pain control approach with recommendations ranging from continuing buprenorphine and supplementing with full opioid agonists as necessary, to discontinuing buprenorphine preoperatively in exchange for full opioid agonists [6,7]. Utilizing a multimodal approach to pain control allows for blockade of pain transmission at multiple sites along the nervous system as well as blockade of a variety of pain receptors with less dangerous side effects (Figure 1 and 2).…”
Section: Introductionmentioning
confidence: 99%
“…Third, many obstetricians refuse to ask their pregnant patients to abstain from buprenorphine because they fear unmonitored and untreatable fetal withdrawal symptoms. A multimodal approach to BMT patients was recently described by Anderson et al 14 We utilized a similar multimodal approach in the 4 obstetric cases described.…”
mentioning
confidence: 99%